Health In Tech shares surge 19.41% premarket after announcing strategic AI platform enhancement collaboration with Ciklum.
ByAinvest
Wednesday, Mar 18, 2026 5:04 am ET1min read
HIT--
Health In Tech (HIT) surged 19.41% in premarket trading following the announcement of a strategic collaboration with Ciklum, a global AI-powered software development firm and AWS Advanced Tier partner, to enhance its AI-driven InsurTech platform. The partnership aims to optimize administrative, sales, and analytics capabilities through cloud-native engineering on AWS, streamline data infrastructure, and unify fragmented workflows into a scalable, AI-native solution. The initiative is expected to improve operational efficiency, expand market reach for self-funded stop-loss insurance, and deliver advanced reporting tools for clients, aligning with Health In Tech’s goal of simplifying healthcare insurance processes. The collaboration underscores the company’s commitment to technological innovation and long-term growth, likely driving investor optimism about enhanced platform adoption and revenue potential.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet